Department of Biology of reproduction (TENON Hospital)
Paris, Île-de-France Region, 75020, France
NCT Number: NCT01239186
This study will analyse the sperm global methylation status of 62 infertile men before assisted reproductive techniques. Some of these patients (20%) present hypomethylation of H19 locus. A global methylation analysis may reveal others imprinting defects.
Looking for future studies?
Notify Me18 year–45 year
Male
Observational
Paris, Île-de-France Region, 75020, France
An increase of the abnormalities of the imprint was brought back at the child's stemming from assisted reproductive techniques. Now abnormalities of methylation could be implied in defects of spermatogenesis and certain abnormalities of development of the male germ cells could be due to modifications abnormal epigenetics.
The objective of this research is to determine the frequency of arisen the abnormalities of methylation at the level of the locus H19 in the sperm cells of barren men presenting an unexplained oligozoospermia and to determine if these changes are a reflection of abnormalities of the profiles of methylation of the whole genome.
The patients will realize a taking of sperm having signed the consent.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
microarray analysis(www.EPIGENOMICS.com)
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
by TUNEL analysis
Time frame: 1 day
Assistance Publique - Hôpitaux de Paris
Other
Acronym: METHYLHOMME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01409837
Genital Diseases, Genital Diseases, Male
Enugu, Enugu State, Nigeria
View Trial DetailsNCT00548977
Azoospermia, Genital Diseases
Tainan, Taiwan
View Trial DetailsNCT04795440
DNA Damage, Embryo
Valencia, Spain
View Trial DetailsNCT06202469
Genital Diseases, Genital Diseases, Male
Novi Sad, Vojvodina, Serbia
View Trial Details